Home / Products / Cancer (Tumor) Cell Lines / NCI-H508
NCI-H508
Datasheet Protocol

NCI-H508

Cat. No. ARC0641
Product Type:

Cancer (Tumor) Cell Lines

Species:

Homo sapiens (Human)

Tissue Source:

Cecum

Growth Properties:

Adherent and suspension

In stock
$1,300.00 / Vial
Ask a Question

Short Description 🔒

NCI-H508 is a cancer cell line of cecum adenocarcinoma, isolated from metastatic; abdominal wall.

Recommended Products

C1orf21 Knockout SK-HEP-1 Polyclonal Cells C1orf21 Knockout SK-HEP-1 Polyclonal Cells Cat. No. ARG32419 LYPLA1 Knockout HT29 Polyclonal Cells LYPLA1 Knockout HT29 Polyclonal Cells Cat. No. ARG14631 CDKL5 Knockout jurkat Polyclonal Cells CDKL5 Knockout jurkat Polyclonal Cells Cat. No. ARG13811 DIXDC1 Knockout K562 Polyclonal Cells DIXDC1 Knockout K562 Polyclonal Cells Cat. No. ARG38819 ADIPOR1 Knockout AGS Polyclonal Cells ADIPOR1 Knockout AGS Polyclonal Cells Cat. No. ARG26469 PBX3 Knockout MES-OV Polyclonal Cells PBX3 Knockout MES-OV Polyclonal Cells Cat. No. ARG6041
Product Details
Cell Engineering
Immortalization
Culture Conditions
Quality Control
Disclaimer

Product Details

Product Type:
Cancer (Tumor) Cell Lines
Species:
Homo sapiens (Human)
Tissue Source:
Cecum
Disease:
Adenocarcinoma
Morphology:
Epithelial-like
Growth Mode:
Adherent and suspension
Age:
55 years
Sex of Donor:
Male
Derived From Site:
Metastatic; Abdominal wall
Size/Quantity:
1 million
Shipping info:
Cryopreserved in vials and shipped on dry ice

Cell Engineering Information

No cell engineering information available.

Immortalization Information

No immortalization information available.

Culture Conditions

Temperature:
37°C
Atmosphere:
5% CO₂

Quality Control

Mycoplasma testing:
Negative for mycoplasma through PCR analysis
Sterility testing:
Daily monitoring confirms that the cells are free from bacterial, yeast, and fungal contamination.
Pathogens:
Cells tested negative for HIV-1, HBV, and HCV.

Disclaimer

Intended Use:
This product is intended for laboratory in vitro use only. It is not intended for diagnostic, therapeutic, or clinical applications.
Disclaimer:
Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability.
Usage:
By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use. This product is provided "AS IS".

Description 🔒

Complete description is available upon request.

Related Products You May Also Like

ARHGAP17 Knockout Raji Polyclonal Cells

ARHGAP17 Knockout Raji Polyclonal Cells

Cat. No. ARG21234
 ACADM Knockout HEK293T Polyclonal Cells

ACADM Knockout HEK293T Polyclonal Cells

Cat. No. ARG25574
 APTX Knockout NCI-H1975 Polyclonal Cells

APTX Knockout NCI-H1975 Polyclonal Cells

Cat. No. ARG31180
 HADHA Knockout NCI-H1299 Polyclonal Cells

HADHA Knockout NCI-H1299 Polyclonal Cells

Cat. No. ARG30696
 DDI2 Knockout A549 Polyclonal Cells

DDI2 Knockout A549 Polyclonal Cells

Cat. No. ARG10011
 EPN1 Knockout 786-O Polyclonal Cells

EPN1 Knockout 786-O Polyclonal Cells

Cat. No. ARG5706